Your browser doesn't support javascript.
loading
Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy.
Miyamoto, Toshihiro; Sanford, David; Tomuleasa, Ciprian; Hsiao, Hui-Hua; Olivera, Leonardo José Enciso; Enjeti, Anoop Kumar; Gimenez Conca, Alberto; Castillo, Teresa Bernal Del; Girshova, Larisa; Martelli, Maria Paola; Guvenc, Birol; Delgado, Alexander; Duan, Yinghui; Garbayo Guijarro, Belen; Llamas, Cynthia; Lee, Je-Hwan.
Afiliação
  • Miyamoto T; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Sanford D; Leukemia/Bone Marrow Transplant Program of BC, Division of Hematology, The University of British Columbia, Vancouver, BC, Canada.
  • Tomuleasa C; Department of Hematology - Medfuture Research Center for Advanced Medicine, Ion Chiricuta Clinical Cancer Center, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Hsiao HH; Department of Internal Medicine, Division of Hematology-Oncology, Kaohsiung Medical University Hospital and Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Olivera LJE; Instituto Nacional de Cancerología, Bogotá, Colombia.
  • Enjeti AK; Calvary Mater Newcastle, University of Newcastle and New South Wales Health Pathology, Waratah, Australia.
  • Gimenez Conca A; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Castillo TBD; Servicio de Hematología y Hemoterapia, University Hospital Central de Asturias, ISPA, IUOPA, Oviedo, Spain.
  • Girshova L; Federal State Budgetary Institution 'Almazov National Medical Research Centre' of the Ministry of Health of the Russian Federation, St. Petersburg, Russia.
  • Martelli MP; Department of Medicine and Surgery - Section of Hematology and Clinical Immunology, Perugia University, 'Santa Maria della Misericordia' Hospital, Perugia, Italy.
  • Guvenc B; Department of Hematology, Faculty of Medicine, Cukurova University, Adana, Turkey.
  • Delgado A; AbbVie, Inc., Singapore, Singapore.
  • Duan Y; AbbVie, Inc., North Chicago, IL, USA.
  • Garbayo Guijarro B; AbbVie, Inc., Madrid, Spain.
  • Llamas C; AbbVie, Inc., North Chicago, IL, USA.
  • Lee JH; Department of Hematology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea.
Leuk Lymphoma ; 63(4): 928-938, 2022 04.
Article em En | MEDLINE | ID: mdl-35147482
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão